aod9604 igf-1 levels study Safety and Tolerability of the Hexadecapeptide AOD 9604 in Humans Insulin-like growth factor-1 deficiency and
Description
The compound is produced as an LPS-free and endotoxin-free research peptide , making it suitable for controlled in vitro and experimental laboratory studies where endotoxin interference must be minimized
NNMT overexpression is associated with obesity and insulin resistance
Patients with vitamin B12 deficiency and concurrent renal or hepatic disease may require increased doses or more frequent administration of methylcobalamin
Research Use Only Legal Disclaimer All products on this site are for research and development use only
